Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Riverside › NPI 1295821296
Physician

Aspen Medical Group, INC

Aspen Medical Group, INC was paid $6.22M by Medicaid between Jan 2018 and Nov 2024, across 117 billing codes. Its largest line is 59425, — 19% of everything it billed.

33Billing provider infoASPEN MEDICAL GROUP, INC
RIVERSIDE, CA 92503
33aNPI1295821296assigned 10/05/2006
28Total paid$6.22M
24GClaims261,497
24DCodes billed117
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Internal Medicine Physician providers in California

Rank by total paid#23 of 2,679
Median peer was paid$13K
This provider vs. median493×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201831,934$1.02M
201937,488$1.05M
202028,834$847K
202136,829$915K
202233,356$690K
202347,568$863K
2024incomplete45,488$838K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
59425 19% 20,734 12,905 $1.19M
59409 Vaginal delivery only (with or without episiotomy and/or forceps) 18% 2,114 2,098 $1.10M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 9.5% 62,208 54,161 $594K
Z1034 4.5% 4,934 3,193 $278K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 4.1% 2,297 2,253 $256K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.8% 9,304 8,639 $236K
76813 3.1% 1,930 1,779 $196K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 2.7% 1,865 1,843 $167K
59430 2.6% 3,240 2,390 $163K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2.6% 4,604 4,518 $159K
97802 2.2% 8,657 8,565 $136K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2.1% 1,501 1,328 $131K
105 more codes
92551 1.9% 11,652 $118K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.8% 1,784 $114K
59514 1.8% 260 $111K
Z1032 1.7% 781 $109K
G0442 Annual alcohol misuse screening, 5 to 15 minutes 1.5% 5,839 $93K
99203 Doctor's office visit, new patient (routine) 1.4% 1,260 $89K
76830 Ultrasound, transvaginal 1.4% 1,367 $87K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.3% 9,082 $80K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 1.2% 545 $77K
99381 <1% 957 $58K
J3490 Unclassified drugs <1% 668 $52K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 6,601 $45K
99238 Hospital discharge day management, 30 minutes or less <1% 1,120 $44K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 462 $37K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 1,919 $35K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,649 $34K
G9920 Screening performed and negative <1% 9,162 $31K
90715 <1% 1,117 $31K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 3,366 $29K
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 5,013 $23K
G8431 Screening for depression is documented as being positive and a follow-up plan is documented <1% 1,654 $22K
90670 <1% 4,398 $22K
58300 <1% 266 $21K
90698 <1% 3,360 $18K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 4,812 $18K
76801 <1% 241 $17K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 14 $17K
90744 <1% 2,461 $14K
88141 <1% 1,184 $14K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 504 $13K
90681 <1% 1,924 $13K
99460 <1% 225 $11K
90658 <1% 1,206 $11K
81025 <1% 4,253 $11K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 175 $9K
90633 <1% 2,413 $7K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 2,075 $7K
90710 <1% 2,099 $6K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 408 $6K
99463 <1% 60 $5K
90677 <1% 410 $4K
11981 <1% 53 $3K
99385 <1% 31 $3K
0500F <1% 136 $2K
99406 <1% 756 $2K
90696 <1% 753 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 510 $2K
3351F <1% 526 $2K
Z6500 <1% 15 $2K
87110 <1% 316 $2K
90655 <1% 200 $2K
99401 <1% 94 $2K
87430 <1% 252 $2K
99462 <1% 60 $2K
90700 <1% 549 $2K
90697 <1% 422 $1K
Z1038 <1% 32 $1K
G9919 Screening performed and positive and provision of recommendations <1% 156 $1K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 3,592 $1K
Z6400 <1% 54 $1K
90648 <1% 276 $1K
81002 <1% 1,065 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,253 $1K
99382 <1% 25 $1K
90734 <1% 267 $965.34
90649 <1% 106 $900.00
99234 <1% 12 $887.48
H1003 Prenatal care, at-risk enhanced service; education <1% 39 $840.99
11976 <1% 24 $825.36
99383 <1% 17 $654.16
90651 <1% 702 $538.09
90686 <1% 911 $440.19
58301 <1% 23 $406.94
83655 <1% 956 $405.85
97803 <1% 17 $374.70
96151 <1% 17 $374.70
90660 <1% 31 $279.00
99188 <1% 176 $249.48
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 429 $241.57
90621 <1% 42 $208.68
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 1,011 $148.92
90680 <1% 32 $135.00
90688 <1% 509 $134.73
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory <1% 1,719 $102.90
85018 <1% 999 $84.05
90685 <1% 37 $35.91
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 220 $33.18
G0270 Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes 0% 95 $0.00
3077F 0% 27 $0.00
99408 0% 14 $0.00
3051F 0% 34 $0.00
3078F 0% 123 $0.00
90472 Immunization administration, each additional vaccine (list separately) 0% 177 $0.00
90707 0% 12 $0.00
1036F 0% 11,570 $0.00
99172 0% 1,118 $0.00
3008F 0% 2,077 $0.00
3044F 0% 148 $0.00
G0008 Administration of influenza virus vaccine 0% 223 $0.00
3079F 0% 119 $0.00
3074F 0% 152 $0.00
G0443 Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes 0% 12 $0.00
3353F 0% 13 $0.00
1220F 0% 13 $0.00
90619 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialEMERUWA, IHEANACHO (MEDICAL DIRECTOR)
Same official

Other billing entities under EMERUWA, IHEANACHO

Full network →
ProviderLocationPaid
Circle City Midwifery & Women's Health Services, INC.Corona, CA$2K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.